Results 11 to 20 of about 2,233,111 (188)
Abstract 078: Managing Clopidogrel Resistance in Neurointervention: Surveying Current Approaches
Stroke: Vascular and Interventional Neurology, 2023 Introduction Due to the variability in patient responses to clopidogrel, adjusting antiplatelet regimen based on platelet function testing has become a widespread practice to reduce thromboembolic complications in neurointervention.
Hyun Woo Kim +6 more
doaj +3 more sources
Managing Clopidogrel Resistance in Neurointervention: Surveying Current Approaches [PDF]
Stroke: Vascular and Interventional NeurologyBackground Because of the variability in patient responses to clopidogrel and to reduce the risk of thromboembolic complications, adjusting the antiplatelet regimen based on platelet function testing has become a widespread practice in neurointervention.
Hyun Woo Kim +7 more
doaj +3 more sources
Ilaprazole and Clopidogrel Resistance in Acute Stroke Patients [PDF]
Biomedicines, 2022 Clopidogrel, an antiplatelet agent used for secondary prevention of cerebrovascular diseases, is often taken with proton pump inhibitors (PPIs). Generally, the combined use of clopidogrel and PPIs causes adverse drug–drug interactions.
Hyun Goo Kang, Seung Jae Lee, Inhwan Lim
exaly +3 more sources
Clopidogrel resistance: What's new? [PDF]
Archives of Cardiovascular Diseases, 2010 The concept of clopidogrel resistance emerged several years ago. Since then, many studies have been performed to elucidate the mechanisms and potential clinical impact of this biological finding. These studies identified complex mechanisms, including drug-drug interactions, genetic polymorphisms and clinical factors, and showed consistently the ...
Cuisset, Thomas +2 more
openaire +3 more sources
RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION [PDF]
Рациональная фармакотерапия в кардиологии, 2015 Aim. To study prevalence of resistance to acetylsalicylic acid, clopidogrel and dual resistance in percutaneous coronary intervention (PCI), to identify clinical risk factors of resistance development, to study effects of concomitant therapy on ...
V. A. Sulimov, E. V. Moroz
doaj +4 more sources
Resistance to clopidogrel: A review of the evidence [PDF]
Journal of the American College of Cardiology, 2005 Current available data show that about 4% to 30% of patients treated with conventional doses of clopidogrel do not display adequate antiplatelet response. Clopidogrel resistance is a widely used term that remains to be clearly defined. So far, it has been used to reflect failure of clopidogrel to achieve its antiaggregatory effect.
Nguyen, Thuy Anh +2 more
openaire +3 more sources
Clinical importance of aspirin and clopidogrel resistance [PDF]
World Journal of Cardiology, 2010 Aspirin and clopidogrel are important components of medical therapy for patients with acute coronary syndromes, for those who received coronary artery stents and in the secondary prevention of ischaemic stroke. Despite their use, a significant number of patients experience recurrent adverse ischaemic events.
Gergely, Feher +9 more
openaire +3 more sources
Arquivos Brasileiros de Cardiologia, 2012 FUNDAMENTO: A dupla terapia antiagregante plaquetária com ácido acetilsalicílico e clopidogrel é pedra angular do tratamento de pacientes submetidos a angioplastia com implante de stents coronarianos. Todavia, parte desses pacientes, a despeito do uso de
Fabrício Braga da Silva +9 more
doaj +4 more sources
Frontiers in Genetics, 2020 In recent years, the relationship between Cyp2C19*2 gene polymorphism and clopidogrel resistance reflected by platelet function assay has been studied extensively, but there is no clear conclusion yet.
Ying Sun +4 more
doaj +3 more sources
Comparison of Clopidogrel and Ticlopidine/Ginkgo Biloba in Patients With Clopidogrel Resistance and Carotid Stenting [PDF]
Frontiers in Neurology, 2019 Background and Purpose: Patients undergoing carotid artery stenting (CAS) who show low responsiveness to clopidogrel may have a higher risk of peri-procedural embolic events.
Jong-Won Chung +10 more
doaj +4 more sources